Table 2.
Evaluation of therapeutic options for refractory chronic cough due to gastroesophageal reflux
Therapeutic options | Evaluations |
Pharmacologically | |
Optimization of PPIs therapy | |
Switch to another PPI | Useful for some refractory cough due to acid reflux |
Doubling the current dose of PPI | Useful for refractory cough due to severe acid reflux |
Add-on therapy | |
Histamine H2 receptor antagonists | Useful for refractory cough due to severe acid reflux and night-time reflux |
TLESRs inhibitors (baclofen) | Useful for refractory cough due to acid or non-acid reflux resistant to PPI therapy |
Gabapentin | Useful for refractory cough due to acid or non-acid reflux resistant to PPI and baclofen therapy |
Surgically | |
Laparoscopic fundoplication | A treatment option for long-term therapy of refractory cough due to acid or non-acid reflux |
Endoscopic therapy or transoral incisionless fundoplication | Not recommended for refractory cough due to reflux on the basis of lack of long-term efficacy |
Radiofrequency augmentation | Not recommended for refractory cough due to reflux on the basis of lack of long-term efficacy |
PPI: Proton pump inhibitor. TLESRs: transient lower esophageal sphincter relaxations.